Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

Concern about the risks of cardiovascular illness in women using combined oral contraceptives (OC) containing the progestagens desogestrel and gestodene prompted two studies of data from the UK General Practice Research Database. We compared the risks of certain cardiovascular illnesses in otherwise...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 1995-12, Vol.346 (8990), p.1589-1593
Hauptverfasser:	JICK, H, JICK, S. S, GUREWICH, V, MYERS, M. W, VASILAKIS, C
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological and medical sciences Birth control Cardiovascular disease Cardiovascular Diseases - chemically induced Cardiovascular Diseases - epidemiology Cardiovascular Diseases - mortality Case-Control Studies Cohort Studies Contraceptives Contraceptives, Oral, Combined - adverse effects Desogestrel - adverse effects Drug toxicity and drugs side effects treatment Estrogens Ethinyl Estradiol - administration & dosage Female Health risks Humans Incidence Levonorgestrel - adverse effects Medical research Medical sciences Norpregnenes - adverse effects Pharmacology. Drug treatments Progestins - adverse effects Risk Factors Thromboembolism Thromboembolism - chemically induced Thromboembolism - epidemiology Toxicity: cardiovascular system Women
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!